The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
Top Cited Papers
- 1 February 2008
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 108 (2), 402-408
- https://doi.org/10.1016/j.ygyno.2007.10.017
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitalsInternational Journal of Gynecologic Cancer, 2006
- Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinomaCancer, 2005
- Who should operate on patients with ovarian cancer? An evidence-based reviewGynecologic Oncology, 2005
- Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian CarcinomasCancer Research, 2005
- Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinomaGynecologic Oncology, 2004
- Preoperative Sensitivity and Specificity for Early-Stage Ovarian Cancer When Combining Cancer Antigen CA-125II, CA 15-3, CA 72-4, and Macrophage Colony-Stimulating Factor Using Mixtures of Multivariate Normal DistributionsJournal of Clinical Oncology, 2004
- A Population-Based Study of Patterns of Care for Ovarian Cancer: Who Is Seen by a Gynecologic Oncologist and Who Is Not?Gynecologic Oncology, 2002
- Ovarian Cancer Screening in Asymptomatic Postmenopausal WomenGynecologic Oncology, 1993
- Serum and Tissue Measurements of CA72-4 in Ovarian Cancer PatientsGynecologic Oncology, 1993
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983